Electromagnetic Emissions and Emotional Disorder, Electromagnetic Emissions and Medication Savings
Conditions
Keywords
Anxiety, Depression, Quality of life, Medication savings, Electromagnetic emissions
Brief summary
Hospital patients usually experience anxiety caused by physiological, psychological and environmental stimuli. This emotional state corresponds to the psychophysiological response to a perceived threat. The investigator's goal is to use a non-drug approach to these problems which would help improve the quality of life of patients, prevent the consumption of anti-anxiety drugs / antidepressants; and thus to reduce the direct cost in terms of treatment, but also to reduce the indirect costs linked to work stoppages and the consumption of the care offer. Working hypothesis: Local magnetic muscle stimulation improves people's well-being and relaxation
Detailed description
Primary objective : Describe the effect of the intervention on the level of anxiety / depression in patients with anxious and / or depressive characteristics Secondary objectives: * Describe the variation in the quality of life of patients before and after the intervention * Describe the variation in drug consumption * Describe the use of post intervention hospitalization * Describe the variation in the quality of sleep before and after the intervention * Describe the timeframe for returning patients to professional activity
Interventions
DEVICEThe emission of electromagnetic with the probes
The patient will be in the lying position, a probe will be positioned in the middle of the chest and the second probe below the xyphoid. The probes will be fixed by a band to keep them in place. The emission of electromagnetic waves is painless.
DEVICEThe emission of electromagnetic without the probes
The patient will be in the lying position, a probe will be positioned in the middle of the chest and the second probe below the xyphoid. The probes will be fixed by a band to keep them in place. The emission of electromagnetic waves is painless.
Sponsors
Clinique Bizet
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Intervention model description
The study concerns adult patients hospitalized for the management of a chronic pathology and / or its complications
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Major patient hospitalized for the management of a chronic pathology and / or its complications; * Patient with a Hospital Anxiety and Depression scale score (HAD) ≥ 8 for items assessing anxiety disorders; AND a HAD score ≥ 8 for the items assessing depressive disorders. * Subject affiliated to a social security scheme or beneficiary of such a scheme * No participation in another clinical study
Exclusion criteria
* Minor patient * Pregnant and breastfeeding women * HAD score \<8 for items evaluating anxiety disorders OR a HAD score \<8 for items evaluating depressive disorders * Major subject protected by law, under curatorship or tutorship
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Improved quality of life in depressed and anxiety patients: Hospital Anxiety and Depression scale | Ten days | Evaluation with Hospital Anxiety and Depression scale |
| Decreased consumption of anti-anxiety and anti-depressant drugs | Ten days | Prescription analysis |
| Improved quality of sleep: Epworth scale | Ten days | Evaluation with Epworth scale |
Countries
France
Outcome results
None listed